Latest Breaking News On - ஆரோக்கியம் ப்ரமோஶந் பணியகம் - Page 10 : comparemela.com
FDA: 137 out of 240,000 vaccinees reported serious side effects
cnnphilippines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnnphilippines.com Daily Mail and Mail on Sunday newspapers.
ICU capacity in Metro Manila at moderate risk, Cordillera in danger zone
cnnphilippines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnnphilippines.com Daily Mail and Mail on Sunday newspapers.
Military coup in Myanmar, Nepal’s constitutional crisis and vaccine rollouts in Southasia
Southasiasphere podcast episode 04: Updates and analysis from around the region. Illustration by Gihan de Chickera
.
In this episode of the roundup, we talk about the ongoing military coup in Myanmar, Nepal’s constitutional crisis, updates on vaccine rollouts across Southasia, and more.
Raisa Wickrematunge: Hi everyone and welcome to Southasiasphere, Himal Southasian’s monthly round-up of news events and developing stories across Southasia. I’m Raisa, and I’m joined by my colleagues Marlon, Shwetha, and Shubhanga. Hi guys.
Marlon Ariyasinghe: Hi
Shwetha Srikanthan: Hi
RW: So our big stories in this edition include the ongoing military coup in Myanmar, Nepal’s constitutional crisis and growing protests against the Prime Minister, and a quick o
February 02, 2021 EIGHTEEN areas have been identified as sites for the conduct of independent phase 3 clinical trials for three candidate vaccines against coronavirus disease 2019 (Covid-19), an official of the Department of Science and Technology (DOST) said.
The vaccines were developed by Johnson & Johnson subsidiary Janssen Pharmaceuticals, Clover Biopharmaceuticals and Sinovac Biotech.
Janssen, which developed candidate vaccine JNJ-78436735, will conduct trials in Makati City, San Pablo and Cabuyao in Laguna, Iloilo City and Bacolod City.
Clover Biopharmaceuticals, Australian subsidiary of Sichuan Clover Biopharmaceuticals of China, will hold clinical trials for its S-Trimer vaccine, or SCB-2019, in the cities of Quezon, Makati, Manila, Taguig, Las Piñas and Muntinlupa, as well as in Calamba, Laguna and Dasmariñas, Cavite.
vimarsana © 2020. All Rights Reserved.